Hiv Virus Articles & Analysis
7 news found
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. Despite progress, an effective animal model that mimics human immune response during HIV/TB co-infection has been lacking, ...
In addition, these new reagents can be applied in various fields, such as mRNA-base vaccine therapy for malignant tumors, protein replacement therapy, and gene editing using mRNA recombination technology. mRNA vaccines protect against infectious diseases like influenza, rabies, HIV and Zika virus infections. This mRNA Transfection Reagent (Catalog: WHM-OB24, unit ...
The analyses were conducted with a simian immunodeficiency virus (SIV) model, commonly used in a preclinical setting as an analog to HIV. ...
Continued the recruitment for two Phase 2 clinical trials of BIT225 for treatment of HIV-1 infection at sites in Australia and Thailand. Continued the design, synthesis and testing of new compounds under its HIV-1 program, with the aim of identifying a next generation lead anti-HIV-1 drug. ...
It is considered to be a regulator of the latent process of the human immunodeficiency virus (HIV) infection. In addition to pseudoUridine, pseudoUridine derivatives such as 1-methylpseudoUridine, 3-methylpseudoUridine, 2'-O-methylpseudoUridine and ultramodified residue 1 -Methyl-3-(3-amino-3-carboxypropyl) pseudoUridine are also popular products of BOC Sciences. ...
Delayed test results often mean HIV patients in Mozambique fail to get timely treatment, but new technology is reducing the need to send tests to far away laboratories, and speeding up test results and HIV treatment. ...
Untreated, HIV-infected infants and young children die more quickly and at higher rates. ...